| Price | 960.00p on 13-04-2026 at 15:50:07 |
|---|---|
| Change | -2.00p -0.21% |
| Buy | 968.00p |
| Sell | 954.00p |
| Last Trade: | Buy 2.00 at 960.00p |
| Day's Volume: | 76,774 |
| Last Close: | 960.00p |
| Open: | 968.00p |
| ISIN: | GB0004559349 |
| Day's Range | 954.00p - 968.00p |
| 52wk Range: | 536.00p - 1,000.00p |
| Market Capitalisation: | £305.69m |
| VWAP: | 953.85787p |
| Shares in Issue: | 31.84m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2 | 960.00p | Suspected BUY Trade |
16:35:29 - 13-Apr-26 |
| Buy* | 2 | 966.00p | SI Trade |
16:26:07 - 13-Apr-26 |
| Sell* | 113 | 955.47p | Ordinary |
16:07:58 - 13-Apr-26 |
| Buy* | 1,758 | 961.38p | Suspected BUY Trade |
16:05:30 - 13-Apr-26 |
| Buy* | 51 | 961.38p | Suspected BUY Trade |
15:53:51 - 13-Apr-26 |
| Buy* | 7 | 968.00p | SI Trade |
15:40:36 - 13-Apr-26 |
| Buy* | 23 | 968.00p | SI Trade |
15:40:35 - 13-Apr-26 |
| Buy* | 8 | 966.00p | SI Trade |
15:40:35 - 13-Apr-26 |
| Buy* | 4 | 961.38p | Suspected BUY Trade |
15:20:48 - 13-Apr-26 |
| Buy* | 15 | 968.00p | SI Trade |
14:31:54 - 13-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Apr 2026 4:40 pm | RNS | Compliance with Market Abuse Regulation |
| 10th Apr 2026 12:06 pm | RNS | Net Asset Value(s) |
| 9th Apr 2026 11:32 am | RNS | Net Asset Value(s) |
| 8th Apr 2026 11:50 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 5:15 pm | RNS | Transaction in Own Shares |
| 7th Apr 2026 11:56 am | RNS | Net Asset Value(s) |
| 7th Apr 2026 10:25 am | RNS-R | Portfolio company Soleno acquired by Neurocrine |
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Apr 2026 12:02 pm | RNS | Net Asset Value(s) |
| 31st Mar 2026 2:55 pm | RNS-R | IBT portfolio company Apellis acquired by Biogen |
